Trilaciclib in Patients With Early-Stage HR-negative Breast Cancer Receiving Adjuvant Chemotherapy

Clinical trial NCT05978648 · RECRUITING

Trial details

NCT number: NCT05978648
Sponsor: wang shusen
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2023-09-20
Primary completion: 2026-12-31
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.